Inflammatory bowel disease
- Crohn's disease
- Ulcerative colitis
Share the diagnosis, the course of the condition and your current specialist care.
Digestive care starts with understanding you.
Digestive concerns can shape meals, travel and everyday plans. Share your diagnosis, recent changes and current care. Our medical team will explain the review, possible treatment routes and the full price of any proposed plan.
Connect your symptoms with your specialist's findings
Your gastroenterologist's summary, relevant endoscopy or imaging reports, recent tests and medication list help our team understand your situation. Include earlier procedures, flares and the care you are receiving now.
Typical issues shared with us:
IBD complications
- Fistulizing Crohn's disease
- Perianal fistulas
Describe any fistula assessment, previous procedures and the question for your reviewing clinician.
Other digestive concerns
- Irritable bowel syndrome (IBS)
- Chronic intestinal inflammation
- Gut microbiota imbalance
Tell us what has been diagnosed and what remains uncertain so the review can be directed appropriately.
All treatments offered are backed by clinical studies.See the research
Bowel & Digestive Health
26 studies- Immunomodulatory effects of extracellular vesicles from mesenchymal stromal cells: Implication for therapeutic approach in autoimmune diseases. (2024)
- Intestinal Inflammation and Regeneration-Interdigitating Processes Controlled by Dietary Lipids in Inflammatory Bowel Disease. (2024)
- Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease. (2022)
- Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges. (2023)
- Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy. (2023)
- A phase IB/IIA study of remestemcel-L, an allogeneic bone marrow-derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: an interim analysis. (2022)
- Efficacy and safety of mesenchymal stem cells in the treatment of perianal fistulas in Crohn's disease: a meta-analysis of randomized controlled trials. (2023)
- Mesenchymal Stem Cells Versus Placebo for Perianal Fistulizing Crohn's Disease: A Systemic Review and Meta-Analysis. (2023)
- Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis therapy. (2024)
- Predictive modeling to evaluate long-term treatment effectiveness of darvadstrocel in patients with complex perianal fistulas in Crohn's disease. (2024)
- Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real-Life Retrospective Multicentre Cohort Study. (2024)
- Refractory Crohn's Disease: Perspectives, Unmet Needs and Innovations. (2024)
- Darvadstrocel for complex perianal fistulas in Crohn's disease: A systematic review and meta-analysis. (2024)
- Localized Administration of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Refractory Perianal Fistula in Crohn's Disease Patients: A Phase II Clinical Trial. (2024)
- Safety and efficacy of stem cell therapy for Crohn's disease: An umbrella review of systematic reviews. (2024)
- Efficacy and safety of stem cell therapy for Crohn's disease: a meta-analysis of randomized controlled trials. (2024)
- Optimizing Treatment Outcomes in Crohn's Disease: A Comprehensive Systematic Review and Meta-Analysis of Regenerative Therapies with Emphasis on Platelet-Rich Plasma. (2024)
- Use of Darvadstrocel (Allogenic Stem Cell Therapy) for Crohn's Fistulas in Real Clinical Practice: The National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study). (2024)
- Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. (2024)
- Reparative immunological consequences of stem cell transplantation as a cellular therapy for refractory Crohn's disease. (2025)
- Perianal fistulizing Crohn's disease: Mechanisms and treatment options focusing on cellular therapy. (2025)
- Allogenic stem cells for Crohn's anal fistulas: Treating early improves the deep remission rate. (2023)
- Safety and Potential Efficacy of Expanded Umbilical Cord-Derived Mesenchymal Stromal Cells in Luminal Ulcerative Colitis Patients. (2024)
- Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease. (2024)
- Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials. (2025)
- The therapeutic efficacy of adipose mesenchymal stem cell-derived microvesicles versus infliximab in a dextran sodium sulfate induced ulcerative colitis rat model. (2024)
A price tied to the treatment proposed for you
The IV starting price applies to a defined IV course after medical review. Local procedures and other assessments are quoted individually. Your proposal identifies treatment, appointments, follow-up, stay and support so you can see the full total before traveling.
Clinical review
We review your diagnosis, records and current care to confirm whether a relevant approach is available.
Named treatment
Your proposal names the treatment, the preparation and the appointments proposed for your situation.
Planned follow-up
Follow-up appointments and recovery monitoring are included in your proposal so you know what to expect.
One written total
One written proposal lists the full treatment price. Stay, support and optional extras are shown separately.
Make your next step clearer
Share your diagnosis and what is affecting daily life. We'll explain the information needed for a review and what a care plan could involve.